Navigation Links
FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis
Date:4/15/2011

acebo. Response was defined as at least 30 percent improvement in the American College of Rheumatology's JIA efficacy variables, along with absence of fever in the preceding seven days. In the long-term follow-up period of the trial there were three cases of macrophage activation syndrome (MAS) among SJIA patients receiving Actemra. MAS is a potentially fatal complication of childhood systemic inflammatory disorders, thought to be caused by excessive activation and proliferation of certain immune cells.

Actemra carries a Boxed Warning for serious infections. Patients treated with Actemra who develop a serious infection should stop Actemra treatment until the infection is controlled. A Boxed Warning is a brief, concise summary of the information that is critical for a prescriber to be aware of, including any restriction on distribution or use, which is included in a black box at the beginning of the drug label.

Changes in certain laboratory test results such as liver tests, blood counts, and cholesterol are not uncommon with Actemra and should be monitored with regular blood tests. The most common side effects in trial participants with SJIA included upper respiratory tract infection, headache, sore throat, and diarrhea.

Actemra is marketed by San Francisco-based Genentech Inc., a subsidiary of the Roche Group.

For more information:

Press Release: FDA Approves New Drug for Rheumatoid Arthritis

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm197108.htm

Approved Drugs: Questions and Answers

http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm054420.htm

National Institute of Arthritis and Musculoskeletal and Skin Diseases – Juvenile Arthritis

h
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves New Medical Device for Form of Brain Cancer
2. FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors
3. FDA Approves Horizant To Treat Restless Legs Syndrome
4. FDA Approves New Treatment for Rare Form of Thyroid Cancer
5. FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Groups Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
6. FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
7. FDA Approves New Treatment for a Type of Late-Stage Skin Cancer
8. FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age
9. FDA Approves Gadavist for Central Nervous System Scans
10. U.S. FDA Approves Bayers Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System
11. FDA Approves Device to Maintain Blood Flow During Artery Bypass Brain Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015 About cardiovascular implants ... narrowing or blockage of blood vessels. Cardiac disease ... high cholesterol, and high blood pressure. Coronary artery ... heart failure are some of the major cardiac ... especially coronary arteries, is one of the most ...
(Date:9/3/2015)... , Sept. 3, 2015 About dry eye syndrome ... eyes due to deficient tear production or quick tear ... of two types: aqueous tear deficient dry eye and ... lacrimal glands do not produce enough tears, whereas meibomian ... secrete lipids to slow tear evaporation and maintain tear ...
(Date:9/3/2015)... 2015  WellCare Health Plans, Inc. (NYSE: WCG ... vice president and chief financial officer, is scheduled to ... on Wednesday, September 9, 2015, at 9:25 a.m. Eastern ... In addition, a replay of the webcast will be ... the live broadcast and the replay will be available ...
Breaking Medicine Technology:Global Cardiovascular Implants Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2
... 2012 QRxPharma (ASX: QRX and OTCQX: QRXPY) announced ... healthy volunteers for MoxDuo® CR, a controlled-release Dual-Opioid® utilising ... MoxDuo CR formulation, encompassing both sustained delivery technology as ... designed to provide at least 12 hours of analgesia ...
... ® and Lung Cancer Alliance hailed the ... conducted by Milliman Inc., an internationally recognized actuarial ... olds at high risk for lung cancer with ... lives, and at lower cost than commonly used screening ...
Cached Medicine Technology:QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR 2QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR 3QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR 4Legacy® and Lung Cancer Alliance Hail the Release of New Study Showing Lung Cancer Screening is Cost Effective 2Legacy® and Lung Cancer Alliance Hail the Release of New Study Showing Lung Cancer Screening is Cost Effective 3
(Date:9/3/2015)... ... September 03, 2015 , ... NanoCytomics LLC today ... technology company that will bring low-cost cancer pre-screening tests to primary care physicians ... and automated technology platform detects and measures cellular changes at the nanoscale level. ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... partner for the Academy of Integrative Health & Medicine (AIHM) Interprofessional Fellowship in ... of Tieraona Low Dog, MD, an internationally renowned educator, physician and thought leader ...
(Date:9/3/2015)... Dallas, TX (PRWEB) , ... September 03, 2015 ... ... three pre-conference workshops included in Patient Experience Conference 2016, to be held April ... independent, non-provider or vendor hosted event bringing together the collective voices of healthcare ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... company the final destination of his six-month, 10,000 mile journey from Santiago, Chile ... the trek—which he calls the “Connecting Las Americas” project—Max crossed six countries in ...
(Date:9/3/2015)... ... ... BedJet released a new version of its award winning personal climate control system ... v2 pre-order campaign blazed past the $1 million dollar mark in only 28 ... Kickstarter. , Simple to use and beautifully designed, the award winning BedJet is the ...
Breaking Medicine News(10 mins):Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 3
... CHICAGO, Nov. 30 Today at the Radiological ... Systems USA announced,that it has expanded its Synapse ... tele-RIS capabilities.(1) The company has also established a,partnership ... will,provide hosted RIS and off site archiving to ...
... new batch of video iPod repairs just announced at the website ipodjuice.com ... ... San Antonio, TX (PRWEB) November 30, 2008 -- With the 5th Generation ... LTD has added several new repair products and services to their website ...
... Siemens Healthcare,( www.siemens.com/healthcare ) will highlight workflow enhancements ... at the 94th Scientific Assembly and Annual Meeting ... November 30 to December 5 at,McCormick Place (Booth ... (Logo: ...
... those with fewer resources , , FRIDAY, Nov. 28 (HealthDay News) ... likely to donate a liver or kidney for transplant than ... national study by Harvard University researchers found that almost 17 ... the time of hospitalization. , In contrast, less than one ...
... Nov. 28 Streamline Health Solutions,Inc. (Nasdaq: STRM ... quarter of fiscal year 2008 ended October 31, 2008 on ... and webcast to discuss,the results on Monday, December 15, at ... conference call to provide additional time for,completion of the necessary ...
... unfit for kids, report claims , , FRIDAY, Nov. 28 ... ponies containing the controversial compounds called phthalates. , Toy ... pet animals that pose a choking hazard. , Consumers ... all these toys are in stores this holiday season, ...
Cached Medicine News:Health News:Fujifilm Sees Significant Growth of Managed Services Business 2Health News:Fujifilm Sees Significant Growth of Managed Services Business 3Health News:Several New 5th Generation iPod Video Repairs Announced Today 2Health News:Siemens Focuses on Role-Based, Context-Sensitive and Knowledge-Driven Solutions 2Health News:Siemens Focuses on Role-Based, Context-Sensitive and Knowledge-Driven Solutions 3Health News:Siemens Focuses on Role-Based, Context-Sensitive and Knowledge-Driven Solutions 4Health News:Siemens Focuses on Role-Based, Context-Sensitive and Knowledge-Driven Solutions 5Health News:Uninsured Likely Organ Donors, But Not Recipients 2Health News:Streamline Health Reschedules Q3 Financial Results Release and Conference Call for Monday, December 15, 2008 2Health News:Beware of Toxic Toys This Holiday Season 2Health News:Beware of Toxic Toys This Holiday Season 3
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride, 0.5% Yeast Extract, 1.0% bacto casamino acids, 0.2% Mag. Sulfate....
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride....
SOC Kit for Bacterial Cells containing 10 x 5mls Sterile growth medium with instructions...
Innovative hemi device combining anatomic design with the advanced material pyrocarbon....
Medicine Products: